STAT

Opinion: It’s time to stop murder by counterfeit medicine

International treaties protect against trafficking women and children, counterfeiting money, and the like. It's time for one targeting counterfeit drug crime.

It was the kind of mistake that’s all too easy to make: Richard Morrow, a pioneer in international public health from Johns Hopkins University, forgot to pack antimalarial medication before traveling to the tropics in 1994. Soon after arriving at his destination in East Africa, he bought “chloroquine” at a pharmacy in the country’s capital, and took the pills as recommended.

On his return to the U.S., he developed a fever, chills, and headache, and soon lapsed into the coma of cerebral malaria, a potentially deadly type of malaria. He survived with quinine treatment, but barely.

A later examination of the medication he bought showed it wasn’t chloroquine

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Plans For Generic Wegovy, Cough Syrup Warnings, And More
Biocon is developing a generic version of Novo Nordisk's Wegovy and is prepared to conduct a clinical trial next year if needed.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.

Related Books & Audiobooks